Zhuhai Sailong Pharmaceutical Co Ltd (002898) — Cash Flow-to-Debt Ratio
Zhuhai Sailong Pharmaceutical Co Ltd (002898) has a Cash Flow-to-Debt Ratio of -0.09x as of September 2025, meaning its operating cash flow of CN¥-28.66 Million could theoretically repay 0% of its total liabilities (CN¥337.07 Million) in one year. See financial agility of Zhuhai Sailong Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhuhai Sailong Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Zhuhai Sailong Pharmaceutical Co Ltd across 13 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Zhuhai Sailong Pharmaceutical Co Ltd.
Annual Cash Flow-to-Debt Ratio for Zhuhai Sailong Pharmaceutical Co Ltd (2013–2025)
Year-by-year debt coverage analysis for Zhuhai Sailong Pharmaceutical Co Ltd. Check 002898 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | CN¥19.06 Million | CN¥447.95 Million | ▲ +133.8% |
| 2024 | -0.13x | CN¥-38.86 Million | CN¥308.95 Million | ▼ -197.9% |
| 2023 | 0.13x | CN¥35.71 Million | CN¥277.96 Million | ▲ +192.5% |
| 2022 | 0.04x | CN¥14.12 Million | CN¥321.64 Million | ▼ -60.5% |
| 2021 | 0.11x | CN¥35.46 Million | CN¥319.12 Million | ▲ +14336.8% |
| 2020 | 0.00x | CN¥174.69K | CN¥226.96 Million | ▲ +100.3% |
| 2019 | -0.26x | CN¥-46.52 Million | CN¥176.95 Million | ▼ -829.0% |
| 2018 | 0.04x | CN¥3.33 Million | CN¥92.30 Million | ▼ -95.9% |
| 2017 | 0.88x | CN¥85.13 Million | CN¥96.50 Million | ▼ -42.6% |
| 2016 | 1.54x | CN¥78.65 Million | CN¥51.21 Million | ▲ +66.8% |
| 2015 | 0.92x | CN¥47.44 Million | CN¥51.53 Million | ▼ -12.3% |
| 2014 | 1.05x | CN¥51.36 Million | CN¥48.93 Million | ▲ +20.5% |
| 2013 | 0.87x | CN¥64.84 Million | CN¥74.44 Million | — |